Literature DB >> 8675678

Bisphosphonates: mechanisms of action.

G A Rodan1, H A Fleisch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8675678      PMCID： PMC507360          DOI： 10.1172/JCI118722

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  46 in total

1.  Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.

Authors:  M Sato; W Grasser
Journal:  J Bone Miner Res       Date:  1990-01       Impact factor: 6.741

2.  Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Authors:  M Sato; W Grasser; N Endo; R Akins; H Simmons; D D Thompson; E Golub; G A Rodan
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

3.  Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.

Authors:  N B Watts; S T Harris; H K Genant; R D Wasnich; P D Miller; R D Jackson; A A Licata; P Ross; G C Woodson; M J Yanover
Journal:  N Engl J Med       Date:  1990-07-12       Impact factor: 91.245

4.  Retention of etidronate in human, dog, and rat.

Authors:  G B Kasting; M D Francis
Journal:  J Bone Miner Res       Date:  1992-05       Impact factor: 6.741

5.  Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.

Authors:  P M Boonekamp; L J van der Wee-Pals; M M van Wijk-van Lennep; C W Thesing; O L Bijvoet
Journal:  Bone Miner       Date:  1986-02

6.  Structure-activity relationships of various bisphosphonates.

Authors:  H Shinoda; G Adamek; R Felix; H Fleisch; R Schenk; P Hagan
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

7.  Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages.

Authors:  M G Cecchini; R Felix; H Fleisch; P H Cooper
Journal:  J Bone Miner Res       Date:  1987-04       Impact factor: 6.741

8.  Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

Authors:  D E Hughes; B R MacDonald; R G Russell; M Gowen
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

9.  The acute-phase response after bisphosphonate administration.

Authors:  S Adami; A K Bhalla; R Dorizzi; F Montesanti; S Rosini; G Salvagno; V Lo Cascio
Journal:  Calcif Tissue Int       Date:  1987-12       Impact factor: 4.333

10.  The influence of 1-hydroxyethane-1,1-diphosphonate and dichloromethanediphosphonate on lysine hydroxylation and cross-link formation in rat bone, cartilage and skin collagen.

Authors:  H L Guenther; H E Guenther; H Fleisch
Journal:  Biochem J       Date:  1981-04-15       Impact factor: 3.857
View more
  172 in total

1.  Enhanced affinity bifunctional bisphosphonates for targeted delivery of therapeutic agents to bone.

Authors:  Jivan N Yewle; David A Puleo; Leonidas G Bachas
Journal:  Bioconjug Chem       Date:  2011-12-05       Impact factor: 4.774

Review 2.  The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.

Authors:  Matthew R Allen
Journal:  Odontology       Date:  2011-01-27       Impact factor: 2.634

3.  Prevalence, pathophysiology, screening and management of osteoporosis in gastric cancer patients.

Authors:  Jung Sub Lim; Jong-Inn Lee
Journal:  J Gastric Cancer       Date:  2011-03-31       Impact factor: 3.720

4.  Osteoporosis and gastrointestinal disease.

Authors:  Seymour Katz; Stuart Weinerman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

Review 5.  Mineral and Bone Disease in Kidney Transplant Recipients.

Authors:  Ariella M Altman; Stuart M Sprague
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

Review 6.  Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases.

Authors:  Sven Otto; Christoph Pautke; Sigurd Hafner; Ronny Hesse; Lea Franziska Reichardt; Gerson Mast; Michael Ehrenfeld; Carl-Peter Cornelius
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2013-05-31

7.  The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K-Akt-NFkappaB pathway in osteosarcoma cells.

Authors:  Ryosuke Inoue; Nori-aki Matsuki; Gao Jing; Takashi Kanematsu; Kihachiro Abe; Masato Hirata
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

8.  Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films.

Authors:  Rebecca S Hayden; Moritz Vollrath; David L Kaplan
Journal:  Acta Biomater       Date:  2013-10-01       Impact factor: 8.947

9.  Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study.

Authors:  Hyung Keun Kim; Ji Hyun Kim; Azlina Amir Abbas; Taek Rim Yoon
Journal:  Clin Orthop Relat Res       Date:  2008-07-30       Impact factor: 4.176

Review 10.  Bisphosphonates in bone diseases.

Authors:  R W Sparidans; I M Twiss; S Talbot
Journal:  Pharm World Sci       Date:  1998-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.